What is Chronic Fatigue Syndrome Treatment Market?
Chronic fatigue syndrome, also known as Myalgic encephalomyelitis, is a chronic disease that lasts for six months and affects the central nervous system and the immune system. The disease leads to musculoskeletal disorders, impairment of long-term memory, and disturbed sleep patterns. This results in a substantial decline in social, occupational, educational, and personal activity among patients. There are no specific biomarkers or tests to diagnose chronic fatigue syndrome. Symptoms include sore throat, muscle pain, headache, and fatigue, which continue for months or years. Diagnosis is difficult; however, certain blood tests are performed to understand the conditions such as infections, and liver and thyroid abnormalities to gauge the patientís condition. This syndrome is likely to affect people in the 40 to 50 age group and stress is one of the major risk factors for developing this syndrome. This has led to significant growth of the global chronic fatigue syndrome treatment market in the forecast period.
The market study is being classified, by Application (Hospitals, Clinics and Research Institutes) and major geographies with country level break-up.
AIM ImmunoTech Inc. (United States), Torrent Pharmaceuticals Ltd. (India), Fortis Healthcare (India), London School of Hygiene L & Tropical Medicine (United Kingdom), Dr Batra's (India), F. Hoffmann-La Roche Ltd (Switzerland), K-PAX Pharmaceuticals (United States), GP Pharm (Spain), Cadila Pharmaceuticals (India), USV (India) and Goodfellow Pharma (Philippines) are some of the key players profiled in the study.
Research Analyst at AMA predicts that Asian and United States Players will contribute to the maximum growth of Global Chronic Fatigue Syndrome Treatment market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Chronic Fatigue Syndrome Treatment market by Type, Application and Region.
On the basis of geography, the market of Chronic Fatigue Syndrome Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Continued Research and Government Support Regarding the Development and Awareness Regarding the Chronic Fatigue Syndrome
- Various Different Market Players and Pharmaceutical Companies are Focusing on the Development of Diagnostics Tests and Treatment for the Disorder
- Rise in Awareness about Chronic Fatigue Syndrome and Treatment through Medications and Therapies
- Lack of Awareness Regarding the Disease
- Increase in Health care Expenditure, and Favorable Reimbursement Policies
- Absence of Information Regarding the Treatments and Drug Combination Available for the Treatment of Symptoms of the Disease
Market Leaders and some development strategies
In May 2019, Hemispherx Biopharma, Inc. announced that they had received positive results for their study involving a blood-based real-time diagnostic test conducted by Stanford University for the identification of moderate to severe ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome). The disease currently has no standardized diagnostic tests available commercially to help the physicians conclude for a definitive diagnosis.
Recently, NIH (The National Institutes of Health) has announced that they had established a new research study for the research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This study will include awarding of four grants with a total cost amounting up to USD 7 million.
Key Target AudienceChronic Fatigue Syndrome Treatment Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase